Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
Condition(s):Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML)Last Updated:June 14, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML)Last Updated:June 14, 2021Completed
Condition(s):Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic/Myeloproliferative Neoplasm; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic/Myeloproliferative NeoplasmLast Updated:March 15, 2024Active, not recruiting
Condition(s):Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Recurrent Adult Acute Myeloid LeukemiaLast Updated:April 18, 2019Terminated
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Stem Cell LeukemiaLast Updated:March 8, 2024Recruiting
Condition(s):LeukemiaLast Updated:December 28, 2017Terminated
Condition(s):Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory Myelodysplastic Syndrome; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Undifferentiated LeukemiaLast Updated:January 11, 2024Recruiting
Condition(s):Myelodysplastic Syndromes; Leukemia, Myelomonocytic, ChronicLast Updated:March 13, 2024Recruiting
Condition(s):Myelomonocytic LeukemiaLast Updated:September 22, 2022Completed
Condition(s):MDS; CMMLLast Updated:February 20, 2024Completed
Condition(s):Leukemia, Myelomonocytic, Chronic; Leukemia-LymphomaLast Updated:April 27, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.